Late Wednesday, Ambit Biosciences Inc. disclosed an S-1 filing with the SEC for an initial public offering (IPO) of its common stock, expected to trade on the Nasdaq market under the symbol "AMBI." The company is seeking to raise up to $57.5 million, though the number of shares and price range were not yet determined.